Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. Cancer J Clin. 2023;73(1):17–48.

Article  Google Scholar 

Cronin KA, Scott S, Firth AU, Sung H, Henley SJ, Sherman RL, Siegel RL, Anderson RN, Kohler BA, Benard VB, et al. Annual report to the nation on the status of cancer, part 1: National cancer statistics. Cancer. 2022;128(24):4251–84.

Article  PubMed  Google Scholar 

Kratzer TB, Jemal A, Miller KD, Nash S, Wiggins C, Redwood D, Smith R, Siegel RL. Cancer statistics for American Indian and Alaska Native individuals, 2022: including increasing disparities in early onset colorectal cancer. Cancer J Clin. 2023;73(2):120–46.

Article  Google Scholar 

Jung KW, Kang MJ, Park EH, Yun EH, Kim HJ, Kong HJ, Im JS, Seo HG. Prediction of Cancer incidence and mortality in Korea, 2023. Cancer Res Treat. 2023;55(2):400–7.

Article  PubMed  PubMed Central  Google Scholar 

Bernardi D, Errante D, Tirelli U, Salvagno L, Bianco A, Fentiman IS. Insight into the treatment of cancer in older patients: developments in the last decade. Cancer Treat Rev. 2006;32(4):277–88.

Article  PubMed  Google Scholar 

Zugazagoitia J, Guedes C, Ponce S, Ferrer I, Molina-Pinelo S, Paz-Ares L. Current challenges in Cancer Treatment. Clin Ther. 2016;38(7):1551–66.

Article  PubMed  Google Scholar 

Borgers JSW, Heimovaara JH, Cardonick E, Dierickx D, Lambertini M, Haanen J, Amant F. Immunotherapy for cancer treatment during pregnancy. Lancet Oncol. 2021;22(12):e550–61.

Article  PubMed  Google Scholar 

Duffy MJ, Synnott NC, Crown J. Mutant p53 as a target for cancer treatment. Eur J Cancer (Oxford, England: 1990). 2017;83:258–65.

Google Scholar 

Chiorean EG, Coveler AL. Pancreatic cancer: optimizing treatment options, new, and emerging targeted therapies. Drug Des Devel Ther. 2015;9:3529–45.

Article  PubMed  PubMed Central  Google Scholar 

Huang Z, Zhou JK, Peng Y, He W, Huang C. The role of long noncoding RNAs in hepatocellular carcinoma. Mol Cancer. 2020;19(1):77.

Article  PubMed  PubMed Central  Google Scholar 

Haghighi R, Castillo-Acobo RY, Ehymayed AHA, Alhili HM, Mirzaei F, Mohammadzadeh Saliani M, Kheradjoo S. A thorough understanding of the role of lncRNA in prostate cancer pathogenesis; current knowledge and future research directions. Pathol Res Pract. 2023;248:154666.

Article  PubMed  Google Scholar 

Entezari M, Ghanbarirad M, Taheriazam A, Sadrkhanloo M, Zabolian A, Goharrizi M, Hushmandi K, Aref AR, Ashrafizadeh M, Zarrabi A, et al. Long non-coding RNAs and exosomal lncRNAs: potential functions in lung cancer progression, drug resistance and tumor microenvironment remodeling. Biomed Pharmacother. 2022;150:112963.

Article  PubMed  Google Scholar 

Herman AB, Tsitsipatis D, Gorospe M. Integrated lncRNA function upon genomic and epigenomic regulation. Mol Cell. 2022;82(12):2252–66.

Article  PubMed  PubMed Central  Google Scholar 

Ferrè F, Colantoni A, Helmer-Citterich M. Revealing protein-lncRNA interaction. Brief Bioinform. 2016;17(1):106–16.

Article  PubMed  Google Scholar 

Li T, Zhou S, Yang Y, Xu Y, Gong X, Cheng Y, Wang Y. LncRNA MNX1-AS1: a novel oncogenic propellant in cancers. Biomed Pharmacother. 2022;149:112801.

Article  PubMed  Google Scholar 

Zhang Y, Tao Y, Liao Q. Long noncoding RNA: a crosslink in biological regulatory network. Brief Bioinform. 2018;19(5):930–45.

Article  PubMed  Google Scholar 

Ma Y, Zhang J, Wen L, Lin A. Membrane-lipid associated lncRNA: a new regulator in cancer signaling. Cancer Lett. 2018;419:27–9.

Article  PubMed  Google Scholar 

Luan Q, Yang R, Lin L, Li X. SNHG8 promotes cell proliferation, migration, and invasion of nasopharyngeal carcinoma cells as an oncogene through miR-588/HMGA2 axis. Can J Physiol Pharmacol. 2022;100(2):158–66.

Article  PubMed  Google Scholar 

Liao X, Zhan W, Zhang J, Cheng Z, Li L, Tian T, Yu L, Li R. Long noncoding RNA LINC01234 promoted cell proliferation and invasion via miR-1284/TRAF6 axis in colorectal cancer. J Cell Biochem. 2020;121(10):4295–309.

Article  PubMed  Google Scholar 

Beaver LM, Kuintzle R, Buchanan A, Wiley MW, Glasser ST, Wong CP, Johnson GS, Chang JH, Löhr CV, Williams DE, et al. Long noncoding RNAs and sulforaphane: a target for chemoprevention and suppression of prostate cancer. J Nutr Biochem. 2017;42:72–83.

Article  PubMed  PubMed Central  Google Scholar 

Xu C, Ping Y, Zhao H, Ning S, Xia P, Wang W, Wan L, Li J, Zhang L, Yu L, et al. LncNetP, a systematical lncRNA prioritization approach based on ceRNA and disease phenotype association assumptions. Oncotarget. 2017;8(70):114603–12.

Article  PubMed  PubMed Central  Google Scholar 

Su X, Zhang J, Luo X, Yang W, Liu Y, Liu Y, Shan Z. LncRNA LINC01116 promotes Cancer Cell Proliferation, Migration and Invasion in gastric Cancer by positively interacting with lncRNA CASC11. Onco Targets Ther. 2019;12:8117–23.

Article  PubMed  PubMed Central  Google Scholar 

Karimi Taheri M, Ghanbari S, Gholipour A, Givi T, Sadeghizadeh M. LINC01116 affects patient survival differently and is dissimilarly expressed in ER + and ER- breast cancer samples. Cancer Rep (Hoboken NJ). 2023;6(8):e1848.

Article  Google Scholar 

Shang B, Li Z, Li M, Jiang S, Feng Z, Cao Z, Wang H. Silencing LINC01116 suppresses the development of lung adenocarcinoma via the AKT signaling pathway. Thorac Cancer. 2021;12(14):2093–103.

Article  PubMed  PubMed Central  Google Scholar 

Chen J, Yuan ZH, Hou XH, Shi MH, Jiang R. LINC01116 promotes the proliferation and inhibits the apoptosis of gastric cancer cells. Eur Rev Med Pharmacol Sci. 2020;24(4):1807–14.

PubMed  Google Scholar 

Wang H, Lu B, Ren S, Wu F, Wang X, Yan C, Wang Z. Long noncoding RNA LINC01116 contributes to Gefitinib Resistance in Non-small Cell Lung Cancer through regulating IFI44. Mol Ther Nucleic Acids. 2020;19:218–27.

Article  PubMed  Google Scholar 

Zhang N, Shuai K, Cheng J, Yang W, Kan Z. LncRNA linc01116 prometes glioma cell migration and invasion by modulation of radixin targeted by miR-31. Int J Clin Exp Pathol. 2019;12(3):1078–86.

PubMed  PubMed Central  Google Scholar 

Bi C, Cui H, Fan H, Li L. LncRNA LINC01116 promotes the development of Colorectal Cancer by Targeting miR-9-5p/STMN1. Onco Targets Ther. 2020;13:10547–58.

Article  PubMed  PubMed Central  Google Scholar 

Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–5.

Article  PubMed  Google Scholar 

Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007;8:16.

Article  PubMed  PubMed Central  Google Scholar 

Fang X, Ren LH, Shrestha SM, Ji Q, Xu Z, Wang D, Ding Q, Liang X, Shi RH. LINC01116 modulates EMT process via binding with AGO1 mRNA in oesophageal squamous cell carcinoma. Biochim et Biophys acta Mol cell Res. 2023;1870(5):119447.

Article  Google Scholar 

Fang YN, Huang ZL, Li H, Tan WB, Zhang QG, Wang L, Wu JL. LINC01116 promotes the progression of epithelial ovarian cancer via regulating cell apoptosis. Eur Rev Med Pharmacol Sci. 2018;22(16):5127–33.

PubMed  Google Scholar 

Hu HB, Chen Q, Ding SQ. LncRNA LINC01116 competes with miR-145 for the regulation of ESR1 expression in breast cancer. Eur Rev Med Pharmacol Sci. 2018;22(7):1987–93.

PubMed  Google Scholar 

Liang W, Wu J, Qiu X. LINC01116 facilitates colorectal cancer cell proliferation and angiogenesis through targeting EZH2-regulated TPM1. J Translational Med. 2021;19(1):45.

Article  Google Scholar 

Lou J, Wang P, Chang K, Wang G, Geng X, Wu Y, Zhang W, Niu G. Knocking down LINC01116 can inhibit the regulation of TGF-β through mir-774-5p axis and inhibit the occurrence and development of glioma. Am J Translational Res. 2021;13(5):5702–19.

Google Scholar 

Wang T, Cao L, Dong X, Wu F, De W, Huang L, Wan Q. LINC01116 promotes tumor proliferation and neutrophil recruitment via DDX5-mediated regulation of IL-1β in glioma cell. Cell Death Dis. 2020;11(5):302.

Article  PubMed